Genetic Technologies received formal notice from the Nasdaq Stock Market stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). As previously disclosed, the Company received a written notice from Nasdaq on July 17, 2023, notifying the Company that it had failed to meet the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Capital Market. To regain compliance with the Listing Rule, the Company’s American Depositary Shares were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, which was achieved on December 28, 2023. Nasdaq has stated that this matter is now closed.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GENE:
- Genetic Technologies files $75M mixed securities shelf
- Genetic Technologies provides details on transformative initiatives
- Genetic Technologies trading halted, news pending
- Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
- Genetic Technologies announces 1-for-100 share consolidation